EDTA: AI 评分 50/100 — AI 分析 (4月 2026)
E-data Corporation manages the Freeny Patent, focusing on licensing and infringement settlements. The company, operating as a subsidiary of Kaba Holding AG, has a market capitalization of $0.00B and trades on the OTC market.
公司概况
概要:
EDTA是做什么的?
EDTA的投资论点是什么?
EDTA在哪个行业运营?
EDTA有哪些增长机遇?
- Expansion of Patent Licensing: E-data Corporation has the opportunity to expand its licensing program for the Freeny Patent. By targeting new industries and applications, the company could generate additional revenue streams. The market for point-of-sale technology is expected to grow, presenting opportunities for licensing the Freeny Patent to new adopters. This expansion could be realized within the next 2-3 years.
- Aggressive Infringement Enforcement: E-data Corporation can pursue a more aggressive strategy of identifying and prosecuting infringers of the Freeny Patent. By actively enforcing its patent rights, the company can generate revenue through settlements and licensing agreements. The potential market for infringement settlements is significant, with many companies potentially infringing on the patent without realizing it. This strategy could yield results within the next 1-2 years.
- Strategic Partnerships: E-data Corporation could form strategic partnerships with technology companies or intellectual property firms to enhance its ability to market and enforce the Freeny Patent. These partnerships could provide access to new markets, technologies, and expertise. The potential market for strategic partnerships is broad, with many companies seeking to leverage intellectual property for competitive advantage. These partnerships could be established within the next year.
- Sale of Patent Rights: E-data Corporation could explore the possibility of selling the Freeny Patent to a larger technology company or intellectual property investment firm. This would provide the company with a one-time infusion of capital and eliminate the need to manage and enforce the patent. The market for patent sales is active, with many companies seeking to acquire valuable intellectual property assets. This sale could be completed within the next 6-12 months.
- Development of New Applications: E-data Corporation could invest in developing new applications for the Freeny Patent. By creating innovative products and services based on the patent, the company could generate new revenue streams and increase the value of its intellectual property. The market for point-of-sale technology is constantly evolving, presenting opportunities for new applications of the Freeny Patent. This development could take 2-3 years to realize.
- E-data Corporation manages the Freeny Patent, a key asset for potential licensing and infringement revenue.
- The company operates as a subsidiary of Kaba Holding AG, providing a degree of financial backing.
- EDTA's market capitalization is $0.00B, reflecting its micro-cap status and limited trading activity.
- The company's beta is -10.67, indicating a high degree of volatility and potential inverse correlation with the market.
- E-data Corporation does not offer a dividend yield, focusing instead on potential capital appreciation through patent monetization.
EDTA提供哪些产品和服务?
- Manages the Freeny Patent related to reproducing information in material objects at point of sale.
- Identifies potential infringers of the Freeny Patent.
- Markets rights under the Freeny Patent to potential licensees.
- Negotiates licensing agreements with companies interested in using the Freeny Patent.
- Negotiates market test agreements to evaluate the potential of the Freeny Patent.
- Negotiates settlements with companies that infringe on the Freeny Patent.
EDTA如何赚钱?
- Generates revenue through licensing agreements for the Freeny Patent.
- Receives payments from settlements with companies found to be infringing on the Freeny Patent.
- Potentially generates revenue through market test agreements.
- Companies in the retail sector that utilize point-of-sale systems.
- Businesses involved in reproducing information on material objects.
- Potential licensees seeking to utilize the technology covered by the Freeny Patent.
- Patent Protection: The Freeny Patent provides a legal monopoly on the covered technology.
- Specialized Expertise: The company has developed expertise in managing and enforcing the Freeny Patent.
- Established Licensing Program: The company has an existing licensing program in place, providing a foundation for future growth.
什么因素可能推动EDTA股价上涨?
- Ongoing: Potential settlements from ongoing infringement cases related to the Freeny Patent.
- Ongoing: Expansion of the licensing program to new industries and applications.
- Upcoming: Strategic partnerships with technology companies or intellectual property firms (timeline: within the next year).
- Upcoming: Potential sale of the Freeny Patent to a larger company (timeline: within the next 6-12 months).
EDTA的主要风险是什么?
- Potential: Legal challenges to the validity of the Freeny Patent.
- Potential: Technological obsolescence of the Freeny Patent.
- Potential: Competition from alternative technologies.
- Ongoing: Limited financial disclosure due to OTC listing.
- Ongoing: Low liquidity and wide bid-ask spread in the OTC market.
EDTA的核心优势是什么?
- Ownership of the Freeny Patent.
- Expertise in patent licensing and enforcement.
- Existing licensing program.
- Subsidiary of Kaba Holding AG.
EDTA的劣势是什么?
- Reliance on a single patent.
- Small size and limited resources.
- OTC listing and limited liquidity.
- Lack of recent financial data.
EDTA有哪些机遇?
- Expansion of licensing program.
- Aggressive infringement enforcement.
- Strategic partnerships.
- Sale of patent rights.
- Development of new applications for the Freeny Patent.
EDTA面临哪些威胁?
- Legal challenges to the validity of the Freeny Patent.
- Technological obsolescence.
- Competition from alternative technologies.
- Economic downturn.
EDTA的竞争对手是谁?
- Annovis Bio Inc — Focuses on drug development, not patent management. — (ANVV)
- Clairon Technologies, Inc. — Specializes in technology solutions, different from patent management. — (CLRN)
- Comint Corp. — Offers communication services, not related to patent management. — (CMNT)
- Firelight Infrastructure Inc. — Focuses on infrastructure projects, unrelated to patent management. — (FRLI)
- Gemsense Holding Group Limited — Operates in the sensor technology sector, distinct from patent management. — (GEMSF)
Key Metrics
- MoonshotScore: 50/100
Company Profile
- CEO: Bert Edward Brodsky
- Headquarters: Port Washington, US
- Employees: 1
- Founded: 2023
AI Insight
- OTC Tier: OTC Other
- Disclosure Status: Unknown
常见问题
What does E-data Corporation do?
E-data Corporation focuses on managing and monetizing the Freeny Patent, which covers systems for reproducing information in material objects at point-of-sale locations. The company's primary activities include identifying potential infringers, marketing the patent rights, negotiating licensing agreements, and pursuing settlements with companies that infringe on the patent. Operating as a subsidiary of Kaba Holding AG, E-data Corporation's business model revolves around leveraging its intellectual property asset to generate revenue through licensing and enforcement.
What do analysts say about EDTA stock?
Due to the company's OTC listing and limited financial disclosure, there is a lack of analyst coverage for EDTA stock. Key valuation metrics are difficult to assess due to the absence of recent financial data. Investors should carefully consider the risks associated with investing in a micro-cap OTC stock with limited public information and analyst insights. The company's growth potential is tied to its ability to successfully monetize the Freeny Patent.
What are the main risks for EDTA?
The main risks for E-data Corporation include legal challenges to the validity of the Freeny Patent, technological obsolescence, and competition from alternative technologies. Additionally, the company faces risks associated with its OTC listing, including limited financial disclosure, low liquidity, and potential regulatory scrutiny. The company's reliance on a single patent also presents a significant concentration risk. Investors should carefully evaluate these risks before investing in EDTA.